Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Huber

Showing results (141-150 of 216) with videos related to

Pageof 22
Sort By:
BMJ (Clinical Research Ed.)|March 18, 2021
Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schoolsAgne Ulyte, Thomas Radtke, Irene A Abela, et al.
Vascular|August 9, 2024
Contraindications to tissue plasminogen activator thrombolysis for acute lower extremity ischemiaNikita Singh, Tyler Santos, Ali Basil Ali, et al.
Nature Communications|March 13, 2020
Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapyMohamed Mahameed, Shatha Boukeileh, Akram Obiedat, et al.
The Journal of Antimicrobial Chemotherapy|August 7, 2023
Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018Bashkim Jaha, Corinne D Schenkel, Lisa Jörimann, et al.
Diagnostic Microbiology and Infectious Disease|August 2, 2015
Unbiased metagenomic sequencing complements specific routine diagnostic methods and increases chances to detect rare viral strainsDagmara W Lewandowska, Osvaldo Zagordi, Andrea Zbinden, et al.
Journal of Virology|November 13, 2009
Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-LAnn J Hessell, Eva G Rakasz, David M Tehrani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2020
Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor-Based Antiretroviral TreatmentAshima Pyngottu, Alexandra U Scherrer, Roger Kouyos, et al.
Cell Reports. Medicine|August 31, 2024
Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccinesMagdalena Schwarzmüller, Cristina Lozano, Merle Schanz, et al.
The Plant Journal : for Cell and Molecular Biology|December 20, 2007
A cysteine-rich receptor-like kinase NCRK and a pathogen-induced protein kinase RBK1 are Rop GTPase interactorsArthur J Molendijk, Benedetto Ruperti, Manoj K Singh, et al.
Leukemia|July 21, 2020
Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemiaOliver Parting, Samantha Langer, Maja Kim Kuepper, et al.
Pageof 22

Showing results (141-150 of 216) with videos related to

Sort By:
Pageof 22
BMJ (Clinical Research Ed.)|March 18, 2021
Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schoolsAgne Ulyte, Thomas Radtke, Irene A Abela, et al.
Vascular|August 9, 2024
Contraindications to tissue plasminogen activator thrombolysis for acute lower extremity ischemiaNikita Singh, Tyler Santos, Ali Basil Ali, et al.
Nature Communications|March 13, 2020
Pharmacological induction of selective endoplasmic reticulum retention as a strategy for cancer therapyMohamed Mahameed, Shatha Boukeileh, Akram Obiedat, et al.
The Journal of Antimicrobial Chemotherapy|August 7, 2023
Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018Bashkim Jaha, Corinne D Schenkel, Lisa Jörimann, et al.
Diagnostic Microbiology and Infectious Disease|August 2, 2015
Unbiased metagenomic sequencing complements specific routine diagnostic methods and increases chances to detect rare viral strainsDagmara W Lewandowska, Osvaldo Zagordi, Andrea Zbinden, et al.
Journal of Virology|November 13, 2009
Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-LAnn J Hessell, Eva G Rakasz, David M Tehrani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 23, 2020
Predictors of Virological Failure and Time to Viral Suppression of First-Line Integrase Inhibitor-Based Antiretroviral TreatmentAshima Pyngottu, Alexandra U Scherrer, Roger Kouyos, et al.
Cell Reports. Medicine|August 31, 2024
Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccinesMagdalena Schwarzmüller, Cristina Lozano, Merle Schanz, et al.
The Plant Journal : for Cell and Molecular Biology|December 20, 2007
A cysteine-rich receptor-like kinase NCRK and a pathogen-induced protein kinase RBK1 are Rop GTPase interactorsArthur J Molendijk, Benedetto Ruperti, Manoj K Singh, et al.
Leukemia|July 21, 2020
Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemiaOliver Parting, Samantha Langer, Maja Kim Kuepper, et al.
Pageof 22